These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 27350255)

  • 1. Concise Review: Human Embryonic Stem Cells-What Have We Done? What Are We Doing? Where Are We Going?
    Ilic D; Ogilvie C
    Stem Cells; 2017 Jan; 35(1):17-25. PubMed ID: 27350255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the glycosphingolipids of human-induced pluripotent stem cells and human embryonic stem cells.
    Säljö K; Barone A; Vizlin-Hodzic D; Johansson BR; Breimer ME; Funa K; Teneberg S
    Glycobiology; 2017 Apr; 27(4):291-305. PubMed ID: 27932383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Derivation of Human Induced Pluripotent Stem Cell (iPSC) Lines and Mechanism of Pluripotency: Historical Perspective and Recent Advances.
    Chhabra A
    Stem Cell Rev Rep; 2017 Dec; 13(6):757-773. PubMed ID: 28918520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug metabolizing enzyme and transporter protein profiles of hepatocytes derived from human embryonic and induced pluripotent stem cells.
    Ulvestad M; Nordell P; Asplund A; Rehnström M; Jacobsson S; Holmgren G; Davidson L; Brolén G; Edsbagge J; Björquist P; Küppers-Munther B; Andersson TB
    Biochem Pharmacol; 2013 Sep; 86(5):691-702. PubMed ID: 23856292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human embryonic and induced pluripotent stem cells in clinical trials.
    Ilic D; Devito L; Miere C; Codognotto S
    Br Med Bull; 2015; 116():19-27. PubMed ID: 26582538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complicity in stem cell research: the case of induced pluripotent stem cells.
    Devolder K
    Hum Reprod; 2010 Sep; 25(9):2175-80. PubMed ID: 20643694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Embryonic Stem Cells in Clinical Trials: Current Overview of Developments and Challenges.
    Golchin A; Chatziparasidou A; Ranjbarvan P; Niknam Z; Ardeshirylajimi A
    Adv Exp Med Biol; 2021; 1312():19-37. PubMed ID: 33159303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Aberrant DNA Methylation Profile of Human Induced Pluripotent Stem Cells Is Connected to the Reprogramming Process and Is Normalized During In Vitro Culture.
    Tesarova L; Simara P; Stejskal S; Koutna I
    PLoS One; 2016; 11(6):e0157974. PubMed ID: 27336948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Derivation of Human Embryonic Stem Cells.
    Crook JM; Kravets L; Peura T; Firpo MT
    Methods Mol Biol; 2017; 1590():115-129. PubMed ID: 28353265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Embryonic stem cells from blastomeres maintaining embryo viability.
    Klimanskaya I
    Semin Reprod Med; 2013 Jan; 31(1):49-55. PubMed ID: 23329636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Trends in Research with Human Pluripotent Stem Cells: Impact of Research and Use of Cell Lines in Experimental Research and Clinical Trials.
    Guhr A; Kobold S; Seltmann S; Seiler Wulczyn AEM; Kurtz A; Löser P
    Stem Cell Reports; 2018 Aug; 11(2):485-496. PubMed ID: 30033087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative transcriptome analysis of hESC- and iPSC-derived corneal endothelial cells.
    Ali M; Khan SY; Kabir F; Gottsch JD; Riazuddin SA
    Exp Eye Res; 2018 Nov; 176():252-257. PubMed ID: 30196069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Techniques of Human Embryonic Stem Cell and Induced Pluripotent Stem Cell Derivation.
    Lewandowski J; Kurpisz M
    Arch Immunol Ther Exp (Warsz); 2016 Oct; 64(5):349-70. PubMed ID: 26939778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted Disruption of the β2-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells.
    Wang D; Quan Y; Yan Q; Morales JE; Wetsel RA
    Stem Cells Transl Med; 2015 Oct; 4(10):1234-45. PubMed ID: 26285657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiotoxicity evaluation using human embryonic stem cells and induced pluripotent stem cell-derived cardiomyocytes.
    Zhao Q; Wang X; Wang S; Song Z; Wang J; Ma J
    Stem Cell Res Ther; 2017 Mar; 8(1):54. PubMed ID: 28279214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human embryonic and induced pluripotent stem cell research trends: complementation and diversification of the field.
    Kobold S; Guhr A; Kurtz A; Löser P
    Stem Cell Reports; 2015 May; 4(5):914-25. PubMed ID: 25866160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of unsafe human induced pluripotent stem cell lines using a robust surrogate assay for pluripotency.
    Polanco JC; Ho MS; Wang B; Zhou Q; Wolvetang E; Mason E; Wells CA; Kolle G; Grimmond SM; Bertoncello I; O'Brien C; Laslett AL
    Stem Cells; 2013 Aug; 31(8):1498-510. PubMed ID: 23728894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of methylation, DNA polymorphisms and microRNAs on HLA-G expression in human embryonic stem cells.
    Verloes A; Spits C; Vercammen M; Geens M; LeMaoult J; Sermon K; Coucke W; Van de Velde H
    Stem Cell Res; 2017 Mar; 19():118-127. PubMed ID: 28131957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human embryonic stem cell cultivation: historical perspective and evolution of xeno-free culture systems.
    Desai N; Rambhia P; Gishto A
    Reprod Biol Endocrinol; 2015 Feb; 13():9. PubMed ID: 25890180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced generation of human embryonic stem cells from single blastomeres of fair and poor-quality cleavage embryos via inhibition of glycogen synthase kinase β and Rho-associated kinase signaling.
    Taei A; Hassani SN; Eftekhari-Yazdi P; Rezazadeh Valojerdi M; Nokhbatolfoghahai M; Masoudi NS; Pakzad M; Gourabi H; Baharvand H
    Hum Reprod; 2013 Oct; 28(10):2661-71. PubMed ID: 23925393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.